Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview
| Autor: | Eloina González-Mancebo, Julio Delgado, Lorena Soto Retes, Esozia Arroabarren, Javier Domínguez-Ortega, Spanish Allergy, Ana I. Tabar |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Allergy
Allergen immunotherapy medicine.medical_specialty Cost-Benefit Analysis Immunology Clinical Decision-Making Clinical practice Severity of Illness Index Antibody Specificity Immunology and Allergy Medicine Humans Adverse effect Intensive care medicine Asthma Clinical Trials as Topic business.industry Age Factors Specific immunotherapy Disease Management Allergic asthma General Medicine Allergens Immunoglobulin E medicine.disease Prognosis respiratory tract diseases Clinical Practice Treatment Outcome Desensitization Immunologic Allergists Immunotherapy business Biomarkers |
| Popis: | The Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and cost of the prolonged course of therapy in asthma. Thus, with the aim of clarifying some aspects with regard to the possible use of AIT in allergic asthma treatment armamentarium, a group of expert allergists from the Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), particularly from the Immunotherapy and Asthma Interest Groups developed a frequently asked questions in clinical practice. This document updates relevant topics on the use of AIT in asthma and could facilitate physician clinical decisions and improve health outcomes for individual patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|